The Impact of Direct-Acting Antiviral Agents on Liver and
Kidney Transplant Costs and Outcomes.
Axelrod DA, Schnitzler MA, Alhamad T,
et a
Am J Transplant.
2018 Apr 27.
Abstract
FULL-TEXT ARTICLE
Incidence of DAA failure and the clinical impact of retreatment in real-life
patients treated in the advanced stage of liver disease: Interim evaluations
from the PITER network
Kondili LA, Gaeta GB, Brunetto MR,
et al
PLoS One. 2017 Oct 4;12
Paper
Direct acting antiviral agents-based
regimen for HCV recurrence after combined liver-kidney transplantation:
results from the ANRS CO23 CUPILT study.
Dharancy S, Coilly A, Fougerou-Leurent C,
et
al
Am J Transplant.
2017 Sep 12.
Abstract
Early
Acute Severe HCV Recurrence After Transplantation: From Universal Mortality
to Cure.
Wadhawan M,
Vij V, Makki K, Bansal N, Kumar A.
J Clin Exp Hepatol. 2017
Mar;7(1):28-32.
Abstract
Hepatitis C Virus Therapy for Decompensated and
Posttransplant Patients.
Dailey F, Ayoub WS.
J Clin Gastroenterol.
2017 Mar;51(3):215-222..
Abstract
Filling the gap between clinical trials and real life in the treatment of
severe HCV recurrence after liver transplantation.
Burra P, Zanetto A.
Transpl Int.
2017 Jan 19. .
Abstract
Risk stratification of allograft failure secondary to hepatitis C recurrence
after liver transplantation.
Shiba H, Hashimoto K, Kelly D, et al
Hepatol Res. 2016 Feb
1.
Abstract
Timing for treatment of HCV recurrence after liver transplantation: the
earlier the better.
Russo FP, Zanetto A, Burra P.
Transpl Int. 2015 Dec
29..
Abstract
Validation of the FIB-4 index for evaluation of fibrosis in patients with
recurrent hepatitis C after living donor liver transplantation: a single
center experience.
Kitajima T, Kaido T, Hamaguchi Y, et al
Hepatol Res. 2015 Nov
19.
Abstract
Impact of Fibrosis Progression on Clinical Outcome in
Patients Treated for Post- Transplant Hepatitis C Recurrence.
Lens S, Mariño Z, Forns X.
Liver Int.
2015 Jul 18
Abstract
FULL-TEXT ARTICLE
Treatment of
Recurrent Hepatitis C Genotype-4 Post-Liver Transplantation with Sofosbuvir
plus Simeprevir.
Ascha M, Ascha M, Zein NN,
Int J Organ Transplant Med.
2015;6(2):86-90.
Paper
Hepatitis C treatment for patients post liver transplant.
Mariño Z, Londoño MC, Forns X.
Curr Opin Organ Transplant.
2015 May 4
Abstract
Post-Liver Transplant Hepatitis C Therapy.
Rahimi RS, O'Leary JG.
Curr Treat Options Gastroenterol.
2015 Mar 27.
Abstract
Modulation of HCV reinfection after orthotopic liver
transplantation by fibroblast growth factor-2 and other non-interferon
mediators.
Van ND, Falk CS, Vondran FW, et al
Gut.
2015 Mar 23.
Abstract
Telaprevir- and Boceprevir-Based Triple Therapy for Hepatitis
C in Liver Transplant Recipients With Advanced Recurrent Disease: A
Multicenter Study.
Verna EC, Saxena V, Burton JR Jr, et al
Transplantation.
2015 Feb 24.
Abstract
Analysis of Post-Liver Transplant Hepatitis C Virus
Recurrence Using Serial Cluster of differentiation Antibody Microarrays.
Rahman W, Tu T,
Budzinska M, Huang P, et al
Transplantation.
2015 Feb 20
Abstract
Management of recurrent hepatitis C virus after liver
transplantation.
Jiménez-Pérez M, González-Grande R, Rando-Muñoz FJ.
World J Gastroenterol. 2014 Nov
28;20(44):16409-16417.
Abstract
Sustained virological response to antiviral therapy improves
survival rate in patients with recurrent HCV infection after liver
transplantation.
Kawaoka T, Takahashi S, Kawakami Y. et
al
Hepatol Res.
2014 Nov 5.
Abstract
Analysis Of The Intrahepatic Ductular Reaction And Progenitor
Cell Responses In Hepatitis C Virus Recurrence Post-Liver Transplantation.
Prakoso E, Tirnitz-Parker JE,
Clouston AD, et al
Liver Transpl. 2014 Sep 20.
Abstract
FULL-TEXT ARTICLE
Efficacy of
immunosuppression monotherapy after liver transplantation: A meta-analysis.
Lan X, Liu MG, Chen HX, et al
World J Gastroenterol.
2014 Sep 14;20(34):12330-40
Paper
Post-liver transplant hepatitis C virus recurrence: An
unresolved thorny problem.
Grassi A,
Ballardini G.
World J Gastroenterol. 2014 Aug
28;20(32):11095-11115.
Abstract
Protease inhibitor-based triple therapy is highly effective
for hepatitis C recurrence after liver transplant: a multicenter experience.
Faisal N, Yoshida EM, Bilodeau M, et al
Ann Hepatol. 2014
Sep-Oct 2014;
Abstract
Aspirin may reduce liver fibrosis progression: Evidence from a
multicenter retrospective study of recurrent hepatitis C after liver
transplantation.
Poujol-Robert A, Boëlle PY, Conti F, et al
Clin Res Hepatol Gastroenterol.
2014 Aug 14.
Abstract
Recurrent HCV after liver transplantation-mechanisms, assessment
and therapy.
Joshi D, Pinzani M,
Carey I, Agarwal K.
Nat Rev Gastroenterol Hepatol. 2014 Jul 15
Abstract
'Recurrence of hepatitis C after liver transplantation.
Vinaixa C, Rubín A, Aguilera V, Berenguer M.
Ann Gastroenterol. 2013;26(4):304-313.
Abstract
Rescue therapy with intravenous silibinin in liver transplant recipients with
recurrent HCV hepatitis - two case reports.
Socha L, Karpińska E, Jurczyk K, Laurans L, et al
Ann Transplant. 2014 Apr 8;19:161-4.
Abstract
FULL-TEXT ARTICLE
Challenges of
recurrent hepatitis C in the liver transplant patient.
Dhanasekaran R, Firpi RJ.
World J Gastroenterol. 2014
Apr 7;20(13):3391-3400
Paper
Liver transplant complications in hepatitis C infected recipients:
recurrence versus rejection.
Gehrau RC, Mas VR, Suh JL, Maluf DG.
Expert Rev Gastroenterol Hepatol.
2014 Mar 18.
Abstract
Long-term maintenance of sustained virological response in liver transplant
recipients treated for recurrent hepatitis C.
Ponziani FR, Viganò R, Iemmolo RM, et al
Dig Liver Dis. 2014 Mar 10.
.
Abstract
Outcome of early vs. deferred antiviral treatment for recurrent hepatitis C in
liver transplant recipients.
Campos-Varela I, Esteban JI, Bes M,
et al
Ann Hepatol.
2014 Mar-Apr 2014;13(2):219-230.
Abstract
Change in composition of inflammatory infiltrate in the course of
hepatitis C reinfection and concomitant acute rejection after orthotopic liver
transplantation.
Ziarkiewicz-Wróblewska B, Wróblewski T, et al
Ann Transplant. 2014 Jan 24;19:41-50.
Abstract
HCV reinfection after liver transplantation].
Herzer K, Papadopoulos-Köhn A, et al
Dtsch Med Wochenschr. 2013
Sep;138(36):1759-64
Abstract
New insights in recurrent HCV infection after liver
transplantation.
Hsu SH, Yeh ML, Wang SN.
Clin Dev Immunol.
2013;2013:890517.
Abstract
Recurrent hepatitis C virus infection post liver
transplantation: impact of choice of calcineurin inhibitor.
Duvoux C, Firpi R, Grazi GL,
et
al
Transpl Int. 2013 Feb 18..
Abstract |
HCV
Liver
Transplants
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader